StonvexLoading…
StonvexStonvexStonvexCore line items from CE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.54B | $10.27B | $10.93B | $9.67B |
Operating Income | $-786.00M | $-720.00M | $1.67B | $1.38B |
Net Income | $-1.17B | $-1.54B | $1.94B | $1.89B |
EPS (Diluted) | $-10.64 | $-14.11 | $17.76 | $17.34 |
Total Assets | $21.70B | $22.84B | $26.60B | $26.27B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.26B | $962.00M | $1.80B | $1.51B |
Free Cash Flow OCF − CapEx | $803.00M | $531.00M | $1.33B | $1.28B |
Shares Outstanding | 109.53M | 109.33M | 108.91M | 108.47M |